Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
| Short Descr | ONC MLNMA AI QUAN ALYS 142 | Medium Descr | ONC MLNMA AI QUAN MASS SPECTROMETRY ALYS 142 | Long Descr | Oncology (melanoma), artificial intelligence (AI)-enabled quantitative mass spectrometry analysis of 142 unique pairs of glycopeptide and product fragments, plasma, prognostic, and predictive algorithm reported as likely, unlikely, or uncertain benefit from immunotherapy agents | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2024-01-01 | Deleted | First appearance of deletion in codebook. |
| 2023-09-30 | Deleted | Code deleted. |
| 2023-01-01 | Added | Code added. |
Get instant expert-level medical coding assistance.